COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 181 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,554,691 | -20.0% | 296,730 | -3.5% | 0.00% | 0.0% |
Q1 2024 | $11,942,216 | +20.2% | 307,631 | -4.7% | 0.00% | 0.0% |
Q4 2023 | $9,931,215 | +42.8% | 322,652 | +3.7% | 0.00% | 0.0% |
Q3 2023 | $6,956,125 | +1.0% | 311,236 | -2.9% | 0.00% | +100.0% |
Q2 2023 | $6,884,795 | -11.9% | 320,372 | -1.7% | 0.00% | -50.0% |
Q1 2023 | $7,815,847 | +3.7% | 325,796 | +0.2% | 0.00% | 0.0% |
Q4 2022 | $7,539,629 | +30.6% | 324,984 | -9.8% | 0.00% | +100.0% |
Q3 2022 | $5,774,000 | -10.2% | 360,454 | -0.6% | 0.00% | 0.0% |
Q2 2022 | $6,427,000 | -18.6% | 362,643 | -6.5% | 0.00% | -50.0% |
Q1 2022 | $7,893,000 | +6.0% | 387,652 | -2.7% | 0.00% | +100.0% |
Q4 2021 | $7,446,000 | +2.3% | 398,532 | +8.1% | 0.00% | 0.0% |
Q3 2021 | $7,280,000 | -15.3% | 368,827 | +1.5% | 0.00% | -50.0% |
Q2 2021 | $8,594,000 | -7.4% | 363,482 | -7.2% | 0.00% | 0.0% |
Q1 2021 | $9,281,000 | +139.8% | 391,587 | +102.6% | 0.00% | +100.0% |
Q4 2020 | $3,871,000 | +1.3% | 193,258 | +5.3% | 0.00% | 0.0% |
Q3 2020 | $3,821,000 | +16.1% | 183,532 | -2.4% | 0.00% | 0.0% |
Q2 2020 | $3,292,000 | +8.3% | 188,105 | +1.1% | 0.00% | 0.0% |
Q1 2020 | $3,039,000 | -23.6% | 186,092 | -3.8% | 0.00% | 0.0% |
Q4 2019 | $3,979,000 | +79.1% | 193,365 | -0.1% | 0.00% | 0.0% |
Q3 2019 | $2,222,000 | -10.8% | 193,561 | +2.1% | 0.00% | 0.0% |
Q2 2019 | $2,492,000 | -11.1% | 189,543 | +2.4% | 0.00% | 0.0% |
Q1 2019 | $2,802,000 | -13.0% | 185,019 | -1.4% | 0.00% | 0.0% |
Q4 2018 | $3,222,000 | +10.9% | 187,647 | -4.8% | 0.00% | 0.0% |
Q3 2018 | $2,906,000 | -48.8% | 197,168 | -17.2% | 0.00% | -50.0% |
Q2 2018 | $5,678,000 | -22.3% | 238,025 | -16.8% | 0.00% | 0.0% |
Q1 2018 | $7,310,000 | +76.5% | 286,098 | +27.5% | 0.00% | +100.0% |
Q4 2017 | $4,142,000 | +276.9% | 224,372 | +114.2% | 0.00% | – |
Q3 2017 | $1,099,000 | -16.3% | 104,732 | -0.2% | 0.00% | – |
Q2 2017 | $1,313,000 | +100.2% | 104,961 | +60.7% | 0.00% | – |
Q1 2017 | $656,000 | -31.5% | 65,305 | +6.1% | 0.00% | – |
Q4 2016 | $958,000 | -4.1% | 61,530 | +18.6% | 0.00% | – |
Q3 2016 | $999,000 | -69.1% | 51,900 | -81.0% | 0.00% | -100.0% |
Q2 2016 | $3,235,000 | -47.2% | 272,981 | -19.1% | 0.00% | -50.0% |
Q1 2016 | $6,129,000 | +729.4% | 337,623 | +1155.5% | 0.00% | – |
Q4 2015 | $739,000 | +24.4% | 26,892 | 0.0% | 0.00% | – |
Q3 2015 | $594,000 | +40.1% | 26,892 | +13.1% | 0.00% | – |
Q2 2015 | $424,000 | – | 23,774 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |